Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and/or survival: observations from a case series.
Casonato
Alessandra
A
Department of Cardiologic, Thoracic, and Vascular Sciences, University of Padua Medical School, Padua, Italy. sandra.casonato@unipd.it
Gallinaro
Lisa
L
Cattini
Maria Grazia
MG
Sartorello
Francesca
F
Pontara
Elena
E
Padrini
Roberto
R
Bertomoro
Antonella
A
Daidone
Viviana
V
Pagnan
Antonio
A
D000017:ABO Blood-Group System / Q000378:metabolism; D016022:Case-Control Studies; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology; D006207:Half-Life; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D009154:Mutation / Q000235:genetics; D010455:Peptides / Q000378:metabolism; D056725:von Willebrand Disease, Type 1 / Q000097:blood / Q000209:etiology*; D014841:von Willebrand Factor / Q000096:biosynthesis* / Q000235:genetics
D000017:ABO Blood-Group System; D010455:Peptides; D014841:von Willebrand Factor; D003894:Deamino Arginine Vasopressin